STM publisher Elsevier, Netherlands, has announced the acquisition of the business assets of Ariadne Genomics, a provider of pathway analysis tools and semantic technologies for life science researchers. Ariadne will be integrated with Elsevier's Corporate Markets division. Financial details of the acquisition are not being disclosed.
Ariadne's flagship product Pathway Studio is widely used by pharmaceutical, agriculture and academic institutions to provide analyses of molecular pathways and disease progression. Pathway Studio is an integrated data mining and visualisation solution that organises relevant facts and relationships from large document collections of genes, proteins, cell processes and diseases.
The tool, powered by Ariadne's MedScan technology, enables visualisation of biological relationships spanning biomedical literature and supports the interpretation of experimental results utilising domain-specific ontologies, taxonomies and dictionaries.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
